We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
326
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $702K | 0.01% |
19,560
-9,213
| -32% | -$318K |
2014 Q1
8 quarters
|
|
327
Deere & Co
DE
$175B
| $701K | 0.01% |
9,109
-8,537
| -48% | -$668K |
2013 Q2
11 quarters
|
|
328
Baxter International
BAX
$13.3B
| $698K | 0.01% |
16,989
-535
| -3% | -$20.4K |
2013 Q2
11 quarters
|
|
329
Littelfuse
LFUS
$9.95B
| $679K | 0.01% |
5,514
+1
| +0% | +$110 |
2015 Q3
2 quarters
|
|
330
DELISTED
Partnerre Ltd
PRE.PRE.CL
| $679K | 0.01% |
24,016
-2,946
| -11% | -$84.4K |
2015 Q4
1 quarter
|
|
331
Ambev
ABEV
$50.3B
| $675K | 0.01% |
130,391
+48,901
| +60% | +$225K |
2013 Q4
9 quarters
|
|
|
LLTC
332
DELISTED
Linear Technology Corp
LLTC
| $670K | 0.01% |
15,028
+153
| +1% | +$6.47K |
2015 Q3
2 quarters
|
|
333
Snap-on
SNA
$18.9B
| $667K | 0.01% |
4,250
+50
| +1% | +$7.66K |
2015 Q2
3 quarters
|
|
|
RSPP
334
DELISTED
RSP Permian, Inc.
RSPP
| $665K | 0.01% |
22,904
-17,024
| -43% | -$400K |
2015 Q1
4 quarters
|
|
335
Caesarstone
CSTE
$93.4M
| $659K | 0.01% |
19,198
-42,016
| -69% | -$1.5M |
2013 Q2
11 quarters
|
|
336
Insulet
PODD
$9.62B
| $659K | 0.01% |
19,864
-18,167
| -48% | -$570K |
2013 Q2
11 quarters
|
|
337
ONE Gas
OGS
$4.69B
| $656K | 0.01% |
10,730
-574
| -5% | -$32.4K |
2014 Q1
8 quarters
|
|
338
Main Street Capital
MAIN
$5.07B
| $651K | 0.01% |
20,759
-2,661
| -11% | -$77.3K |
2015 Q4
1 quarter
|
|
339
Willis Towers Watson
WTW
$28.8B
| $650K | 0.01% |
+5,474
| New | +$630K |
2016 Q1
0 quarters
|
|
340
Boston Beer
SAM
$1.84B
| $646K | 0.01% |
+3,491
| New | +$636K |
2016 Q1
0 quarters
|
|
341
Vanguard Dividend Appreciation ETF
VIG
$113B
| $645K | 0.01% |
7,933
-52
| -0.7% | -$3.99K |
2013 Q2
11 quarters
|
|
342
Eastman Chemical
EMN
$7.3B
| $640K | 0.01% |
8,859
+2
| +0% | +$131 |
2015 Q2
3 quarters
|
|
343
DELISTED
Monroe Capital Corp
MRCC
| $631K | 0.01% |
45,560
-1,877
| -4% | -$23.4K |
2015 Q4
1 quarter
|
|
344
BP
BP
$125B
| $630K | 0.01% |
24,821
+7,039
| +40% | +$178K |
2013 Q2
11 quarters
|
|
345
ScottsMiracle-Gro
SMG
$3.16B
| $623K | 0.01% |
8,560
-565
| -6% | -$38.4K |
2015 Q1
4 quarters
|
|
346
iShares Global Energy ETF
IXC
$3.21B
| $610K | 0.01% |
+20,680
| New | +$566K |
2016 Q1
0 quarters
|
|
347
iShares Russell Mid-Cap ETF
IWR
$56.6B
| $606K | 0.01% |
14,880
-1,200
| -7% | -$45.7K |
2014 Q1
8 quarters
|
|
348
Apollo Commercial Real Estate
ARI
$824M
| $603K | 0.01% |
36,978
-5,657
| -13% | -$90.9K |
2015 Q4
1 quarter
|
|
349
DELISTED
Dominion Diamond Corporation
DDC
| $597K | 0.01% |
53,870
-1,080
| -2% | -$11.8K |
2014 Q1
8 quarters
|
|
|
CARB
350
DELISTED
Carbonite Inc
CARB
| $592K | 0.01% |
74,290
-13,481
| -15% | -$110K |
2015 Q2
3 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.